263 related articles for article (PubMed ID: 34440306)
1. Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma.
Rothzerg E; Ho XD; Xu J; Wood D; Märtson A; Kõks S
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440306
[TBL] [Abstract][Full Text] [Related]
2. A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth.
Liu SH; Zhu JW; Xu HH; Zhang GQ; Wang Y; Liu YM; Liang JB; Wang YX; Wu Y; Guo QF
Mol Cell Biochem; 2017 Jun; 430(1-2):47-56. PubMed ID: 28190168
[TBL] [Abstract][Full Text] [Related]
3. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
5. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
6. LncRNA ROR1-AS1 accelerates osteosarcoma invasion and proliferation through modulating miR-504.
Wu X; Yan L; Liu Y; Shang L
Aging (Albany NY); 2020 Dec; 13(1):219-227. PubMed ID: 33401251
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3.
Sun J; Wang X; Fu C; Wang X; Zou J; Hua H; Bi Z
Mol Biol Rep; 2016 May; 43(5):427-36. PubMed ID: 27022737
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ZMIZ1-AS1 promotes osteosarcoma progression by stabilization of ZMIZ1.
Zhou Y; Jin Q; Chang J; Zhao Z; Sun C
Cell Biol Toxicol; 2022 Dec; 38(6):1013-1026. PubMed ID: 34508303
[TBL] [Abstract][Full Text] [Related]
9. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression.
He JW; Li DJ; Zhou JH; Zhu YL; Yu BQ
Biochem Biophys Res Commun; 2020 Jun; 526(3):670-677. PubMed ID: 32248969
[TBL] [Abstract][Full Text] [Related]
10. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
Cui H; Zhao J
J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1.
Zhang YX; Cui HX; Liu L; Yi GK
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6045-6052. PubMed ID: 31364121
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MATN1-AS1 for Prediction of Prognosis in Osteosarcoma Patients and Its Cellular Function.
Liu Y; Wang D; Ji Q; Yan J
Mol Biotechnol; 2022 Jan; 64(1):66-74. PubMed ID: 34542816
[TBL] [Abstract][Full Text] [Related]
13.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
14. LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression.
Yao W; Hou J; Liu G; Wu F; Yan Q; Guo L; Wang C
Cancer Biomark; 2023; 36(1):1-16. PubMed ID: 35912730
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ASMTL-AS1 deteriorates the oncogenicity of osteosarcoma by decoying microRNA-342-3p and consequently raising ADAM9 expression.
Hou C; Sun F; Sun M
Biochem Biophys Res Commun; 2021 Nov; 579():89-96. PubMed ID: 34597997
[TBL] [Abstract][Full Text] [Related]
16. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
Cai L; Lv J; Zhang Y; Li J; Wang Y; Yang H
J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
[TBL] [Abstract][Full Text] [Related]
17. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.
Zhang CL; Zhu KP; Ma XL
Cancer Lett; 2017 Jun; 396():66-75. PubMed ID: 28323030
[TBL] [Abstract][Full Text] [Related]
18. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
Kun-Peng Z; Chun-Lin Z; Xiao-Long M
Int J Biol Sci; 2017; 13(9):1180-1191. PubMed ID: 29104509
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
[TBL] [Abstract][Full Text] [Related]
20. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
